Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 20CNS 11Sarcoma 8Head & Neck 8Thoracic 6Breast 6Genitourinary 4Dermatologic 3Tumor-Agnostic 1Gynecologic 1Classical hematology 1

Conditions

Wilms Tumor 1Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Magnetic Resonance Spectroscopy 101Specimen Handling 83pembrolizumab 76enzalutamide 63Nivolumab 59Gemcitabine 56Docetaxel 50apalutamide 42Radiosurgery 42Abiraterone Acetate 40Prednisone 39Androgen Antagonists 39Cisplatin 37Biopsy 37darolutamide 36cabozantinib 32Radiotherapy 32Pluvicto 28Carboplatin 28abiraterone 27Ipilimumab 25enfortumab vedotin 24durvalumab 24Radiation 23atezolizumab 22X-Rays 21Leuprolide 20Standard of Care 19olaparib 18avelumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Surgical Procedures, Operative × Genitourinary × 90 days × Clear all
NCT03924856 2026-05-28

KEYNOTE-866

Merck Sharp & Dohme LLC

Phase 3 Completed
907 enrolled
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT05826509 2026-05-08

SUGAR

Institut Claudius Regaud

Phase 2 Active not recruiting
240 enrolled
Genitourinary

Prostatic Neoplasms

NCT04322318 2026-05-05

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Children's Oncology Group

Phase 2 Recruiting
256 enrolled
Genitourinary

Wilms Tumor

NCT04286386 2026-04-29

Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam

M.D. Anderson Cancer Center

Active not recruiting
130 enrolled
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡